CorNova, Inc. Product Pipeline Analysis

SUMMARY

CorNova, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a CorNova, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List Of Tables 5
1.2 List of Figures 6
2 Company Overview 7
2.1 Key Information 7
2.2 Industry Outlook -- Cardiovascular Devices 7
3 Major Products and Services 8
3.1 Overview 8
4 Competitors 9
5 Locations And Subsidiaries 10
5.1 Head Office 10
5.2 Other Locations & Subsidiaries 10
6 CorNova, Inc. Pipeline Products 11
6.1 CorNova, Inc. Product Pipeline Analysis 11
6.1.1 CorNova, Inc. Pipeline Products By Equipment Type 11
6.1.2 CorNova, Inc. Pipeline Products By Development Stage 12
6.1.3 CorNova, Inc. Pipeline Products By Therapy Area 12
6.2 Valecor Platinum Coronary Stent System 13
6.2.1 Product Description 13
6.2.2 Product Status 13
6.2.3 Product Milestone 13
6.3 Valecor CoCr Coronary Stent System 14
6.3.1 Product Description 14
6.3.2 Product Status 14
6.3.3 Product Milestone 15
6.3.4 Product Patent Details 15
6.4 Halo Angioplasty Balloon Catheter 15
6.4.1 Product Description 15
6.4.2 Product Status 16
6.4.3 Product Patent Details 16
7 Appendix 17
7.1 Methodology 17
7.1.1 Coverage 17
7.1.2 Secondary Research 18
7.1.3 Primary Research 18
7.1.4 Expert Panel Validation 19
7.2 Contact Us 19
7.3 About Global Markets Direct 19
7.4 Disclaimer 19

1.1 List of Tables
Table 1: CorNova, Inc.,Key Facts 7
Table 2: CorNova, Inc., Other Locations 10
Table 3: CorNova, Inc. Pipeline Products by Equipment Type 11
Table 4: CorNova, Inc. Pipeline Products By Development Stage 12
Table 5: CorNova, Inc. Pipeline Products By Therapy Area 12

1.2 List of Figures
Figure 1: CorNova, Inc. Pipeline Products By Development Stage 12
Figure 2: Global Markets Direct Methodology 17